Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Sep;28(9):1938–1941. doi: 10.1128/jcm.28.9.1938-1941.1990

Evaluation of the updated Vitek yeast identification data base.

M el-Zaatari 1, L Pasarell 1, M R McGinnis 1, J Buckner 1, G A Land 1, I F Salkin 1
PMCID: PMC268082  PMID: 2229376

Abstract

Using 398 isolates of yeasts and yeastlike fungi comprising 9 genera and 26 species, as well as the hyphomycete Geotrichum candidum and the achlorophyllous alga Prototheca wickerhamii, we compared the API 20C yeast identification system with the modified Vitek yeast identification system with an expanded data base. We found 11 discrepancies between the two systems: five (1.3%) of the isolates (Blastoschizomyces capitatus, 1; Candida albicans, 1; Hansenula anomala, 1; Rhodotorula minuta, 2) had biocodes not included in the expanded Vitek data base, and six (1.5%) of the isolates (Candida lusitaniae, 1; Candida parapsilosis, 1; Cryptococcus uniguttulatus, 1; H. anomala, 1; Torulopsis candida, 2) were misidentified by the Vitek system. Overall, the efficacy of the Vitek system compares favorably with that of the API 20C in the identification of clinically important yeasts.

Full text

PDF
1938

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahearn D. G., McGlohn M. S. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. J Clin Microbiol. 1984 Mar;19(3):412–416. doi: 10.1128/jcm.19.3.412-416.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buesching W. J., Kurek K., Roberts G. D. Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol. 1979 May;9(5):565–569. doi: 10.1128/jcm.9.5.565-569.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cho S. Y., Choi H. Y. Opportunistic fungal infection among cancer patients. A ten-year autopsy study. Am J Clin Pathol. 1979 Oct;72(4):617–621. doi: 10.1093/ajcp/72.4.617. [DOI] [PubMed] [Google Scholar]
  4. Hasyn J. J., Buckley H. R. Evaluation of the AutoMicrobic system for identification of yeasts. J Clin Microbiol. 1982 Nov;16(5):901–904. doi: 10.1128/jcm.16.5.901-904.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Horn R., Wong B., Kiehn T. E., Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985 Sep-Oct;7(5):646–655. doi: 10.1093/clinids/7.5.646. [DOI] [PubMed] [Google Scholar]
  6. Karabinis A., Hill C., Leclercq B., Tancrède C., Baume D., Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988 Mar;26(3):429–432. doi: 10.1128/jcm.26.3.429-432.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kwon-Chung K. J., Riggsby W. S., Uphoff R. A., Hicks J. B., Whelan W. L., Reiss E., Magee B. B., Wickes B. L. Genetic differences between type I and type II Candida stellatoidea. Infect Immun. 1989 Feb;57(2):527–532. doi: 10.1128/iai.57.2.527-532.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kwon-Chung K. J., Wickes B. L., Merz W. G. Association of electrophoretic karyotype of Candida stellatoidea with virulence for mice. Infect Immun. 1988 Jul;56(7):1814–1819. doi: 10.1128/iai.56.7.1814-1819.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kwon-Chung K. J., Wickes B. L., Salkin I. F., Kotz H. L., Sobel J. D. Is Candida stellatoidea disappearing from the vaginal mucosa? J Clin Microbiol. 1990 Mar;28(3):600–601. doi: 10.1128/jcm.28.3.600-601.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Land G. A., Harrison B. A., Hulme K. L., Cooper B. H., Byrd J. C. Evaluation of the new API 20C strip for yeast identification against a conventional method. J Clin Microbiol. 1979 Sep;10(3):357–364. doi: 10.1128/jcm.10.3.357-364.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Land G., Stotler R., Land K., Staneck J. Update and evaluation of the AutoMicrobic yeast identification system. J Clin Microbiol. 1984 Oct;20(4):649–652. doi: 10.1128/jcm.20.4.649-652.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Libertin C. R., Wilson W. R., Roberts G. D. Candida lusitaniae--an opportunistic pathogen. Diagn Microbiol Infect Dis. 1985 Jan;3(1):69–71. doi: 10.1016/0732-8893(85)90069-0. [DOI] [PubMed] [Google Scholar]
  13. Meunier-Carpentier F., Kiehn T. E., Armstrong D. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med. 1981 Sep;71(3):363–370. doi: 10.1016/0002-9343(81)90162-5. [DOI] [PubMed] [Google Scholar]
  14. Oblack D. L., Rhodes J. C., Martin W. J. Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol. 1981 Feb;13(2):351–355. doi: 10.1128/jcm.13.2.351-355.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pfaller M. A., Preston T., Bale M., Koontz F. P., Body B. A. Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates. J Clin Microbiol. 1988 Oct;26(10):2054–2058. doi: 10.1128/jcm.26.10.2054-2058.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Salkin I. F., Land G. A., Hurd N. J., Goldson P. R., McGinnis M. R. Evaluation of YeastIdent and Uni-Yeast-Tek yeast identification systems. J Clin Microbiol. 1987 Apr;25(4):624–627. doi: 10.1128/jcm.25.4.624-627.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Salkin I. F., Schadow K. H., Bankaitis L. A., McGinnis M. R., Kemna M. E. Evaluation of Abbott Quantum II yeast identification system. J Clin Microbiol. 1985 Sep;22(3):442–444. doi: 10.1128/jcm.22.3.442-444.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wingard J. R., Merz W. G., Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med. 1979 Oct;91(4):539–543. doi: 10.7326/0003-4819-91-4-539. [DOI] [PubMed] [Google Scholar]
  19. Wright S. H., Czaja A. J., Katz R. S., Soloway R. D. Systemic mycosis complicating high dose corticosteroid treatment of chronic active liver disease. Am J Gastroenterol. 1980 Nov;74(5):428–432. [PubMed] [Google Scholar]
  20. Zwadyk P., Jr, Tarlton R. A., Proctor A. Evaluation of the API 20C for identification of yeasts. Am J Clin Pathol. 1977 Mar;67(3):269–271. doi: 10.1093/ajcp/67.3.269. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES